BioCentury | Jan 9, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...inhibitors of MK2 and testing them in animal models of diabetes. The authors have cofounded Tabomedex Biosciences LLC...
...application filed by Columbia University; additional application in preparation covering unpublished MK2 inhibitors; licensed by Tabomedex...
Items per page:
1 - 1 of 1
BioCentury | Jan 9, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...inhibitors of MK2 and testing them in animal models of diabetes. The authors have cofounded Tabomedex Biosciences LLC...
...application filed by Columbia University; additional application in preparation covering unpublished MK2 inhibitors; licensed by Tabomedex...
Items per page:
1 - 1 of 1